Assessment of the therapeutic potential of cytokines, cytotoxic drugs and effector cell populations for the treatment of multiple myeloma using the 5T33 murine myeloma model-Reference-Cited by-同舟云学术

Assessment of the therapeutic potential of cytokines, cytotoxic drugs and effector cell populations for the treatment of multiple myeloma using the 5T33 murine myeloma model

Published:1995-08 Issue:4 Volume:73 Page:326-332
ISSN:0818-9641
Container-title:Immunology and Cell Biology
language:en
Short-container-title:

Author:

MANNING LINDA S,CHAMBERLAIN NARELLE L,LEAHY MICHAEL F,CORDINGLEY FRANK T

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/icb199550.pdf

Reference26 articles.

1. Myeloma;Jacobs;Dis. Month,1990

2. Newer approaches to the therapy of multiple myeloma;Kyle;Blood,1990

3. A progress report on the treatment of 157 patients with advanced cancer using lymphckine-ativated killer cells and interleukin-2 or highdose interleukin-2 alone;Rosenberg;N. Engl. J. Med.,1987

4. Human lymphokine-activated killer ceils (LAK ceils) as a potential immunotherapeutic modality;Grimm;Biochim. Biophys. Acta,1986

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-intensity pulsed ultrasound enhances neurite growth in serum-starved human neuroblastoma cells;Frontiers in Neuroscience;2023-11-20

2. The use of animal models in multiple myeloma;Morphologie;2015-06

3. Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor αSu/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma;Cancer Research;2013-05-03

4. Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells;Gene Therapy;2011-01-06

5. Mouse Models of Human Myeloma;Hematology/Oncology Clinics of North America;2007-12